Actress Christina Applegate revealed that her 2021 diagnosis of multiple sclerosis was incorrect after updated imaging showed she does not have the condition. The Christina Applegate misdiagnosis news arrived on her MeSsy podcast, where she shared both her relief and the confusing reality of living with unexplained mobility loss [2]. While the announcement surprised the public, specialists stress that ruling out conditions that mimic multiple sclerosis remains one of the hardest challenges in neurology.
The Christina Applegate Misdiagnosis on MeSsy
Applegate returned to MeSsy after a seven-month break to describe what happened when her doctor reviewed updated brain scans [4]. Her doctor walked in and said, “Congratulations, you don’t have MS.” While friends greeted the news with joy, Applegate felt stunned instead of happy [3]. She explained that hearing she lacked the disease left her feeling unmoored, noting that a formal diagnosis had provided answers and a community [4].
The sudden change brought complex grief because both she and Jamie-Lynn Sigler had become public voices for people living with the disease. Applegate told listeners she felt like she had let everybody down after years of advocacy. “This may come as great news, but to me, it comes as like, very like I’m back at square one,” Applegate said on the show [2]. Having no clear explanation made her daily pain feel even more confusing.
Her physical struggles did not stop when the label was removed. “Nothing magical happened when she said, “You don’t have MS.” Nothing magical happened,” Applegate said during the broadcast [4]. Neurologist Dr. Marwa Kaisey from Cedars-Sinai Medical Center in Los Angeles joined the show to discuss diagnostic uncertainty [2]. Kaisey reassured both hosts that misdiagnosing multiple sclerosis is far more frequent than the public realizes [4].
Severe Symptoms from the 2021 Evaluation
Applegate’s medical ordeal began in January 2021 when she first noticed numbness creeping through her toes. The loss of feeling spread into both legs before bodily pain followed. Her physician ordered extensive evaluations, including spinal tap tests and brain magnetic resonance imaging scans showing nearly 40 lesions [1]. Because multiple sclerosis involves the immune system attacking myelin in the central nervous system, doctors concluded those lesions matched the disease [6].
During production of the final season of Dead to Me on Netflix, her mobility declined so much that crew members adjusted the filming schedule to support her. She used a wheelchair between takes and said in a 2022 interview with The New York Times that she could no longer walk without a cane. By 2023, she indicated she might step away from on-camera acting, committing instead to physical therapy three times a week [3]. Walking unassisted remained impossible.
Her health challenges extended beyond walking difficulties. In a 2025 podcast, Applegate shared that she had been in the hospital upwards of 30 times for bouts of vomiting, diarrhea, and pain. Talking to Conan O’Brien on Conan O’Brien Needs a Friend, she admitted that heat and fatigue keep her housebound [6]. She also chronicled her journey in her 2026 memoir, You with the Sad Eyes, and spoke with Robin Roberts on ABC News about facing an incurable illness [2].
B-Cell Therapy Clues and New Brain Scans
The turning point in Applegate’s case began when her medical team paused an ongoing infusion therapy. Her doctor wanted to observe how her immune system responded to the change, focusing on circulating B cells that play a key part in multiple sclerosis disease activity. Stopping such targeted immunotherapy should cause measurable shifts in immune cell populations. When her B-cell count stayed flat without rising or falling, her physician grew suspicious about whether the original diagnosis was correct [3].
That biological clue prompted a re-evaluation of her previous scans using newer imaging technology [1]. Brain lesions often appear as white patches on magnetic resonance imaging scans, but they are not unique to multiple sclerosis [5]. Migraines, vascular changes, and other inflammatory disorders can produce similar marks on brain tissue. Analyzing Applegate’s scans with newer software revealed that her brain features lacked the specific hallmarks that confirm demyelinating disease [1].
Her doctor delivered the verdict in person, telling Applegate that she had never had multiple sclerosis [3]. The conclusion brought emotional disorientation because it removed her explanatory framework without curing her physical impairment. “You don’t get misdiagnosed and then all of a sudden I’m better,” Applegate said on MeSsy, noting her symptoms had actually worsened [4]. Her care team plans an extensive investigation to identify what underlying illness has caused her health problems since 2021 [3].
Why Multiple Sclerosis Lacks a Single Test
The main reason diagnostic errors happen is that multiple sclerosis cannot be verified by a single test. Bruce Bebo, chief research and medical affairs officer at the National Multiple Sclerosis Society, compares diagnosing the disease to putting a puzzle together [1]. Neurologists must review medical histories, reflexes, and scans to rule out competing conditions before reaching a verdict. Dr. Philip De Jager from Columbia University Vagelos College of Physicians and Surgeons explains that multiple sclerosis remains a diagnosis of exclusion, meaning doctors must systematically eliminate alternative causes [5].
To guide evaluations, clinicians use the McDonald criteria, which were revised in 2024 and published in The Lancet Neurology in 2025 to include additional biological markers [5]. However, applying these guidelines requires subjective judgment that can lead to mistakes. Dr. Ilana Katz Sand, a neurologist at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, explains that misdiagnosis often happens when clinicians fail to weigh diagnostic red flags carefully [4]. When unusual MRI findings are misread, conditions like migraine or neuromyelitis optica can be mistaken for multiple sclerosis [1].
Symptoms such as fatigue, dizziness, tingling, muscle weakness, and numbness appear in many other illnesses [2]. Because early signs come and go unpredictably, separating multiple sclerosis from other disorders is difficult [4]. The discussion around the Christina Applegate misdiagnosis reveals how initial clinical evaluations can latch onto surface similarities while missing subtle contradictions [1]. Applying criteria without caution means patients can spend years taking medications meant for a disease they do not have [5].
Rates of Diagnostic Error in Clinical Research
While national headlines might make Applegate’s case appear unusual, clinical data shows that diagnostic mistakes happen often [2]. Dr. Kaisey reported that in her research examining patient referrals, nearly one in five people told they had multiple sclerosis did not actually have the condition [3]. A 2019 study led by Kaisey found that up to 19 percent of patients evaluated at two major academic centers carried an incorrect diagnosis [5]. Many of those individuals had lived with the mistaken label for years while taking powerful medications [6].
Scientific literature confirms that diagnostic error rates persist in healthcare settings around the world. A detailed 2024 systematic review and meta-analysis published in the Multiple Sclerosis Journal by W. E. Zürrer and colleagues synthesized data from 62 distinct studies to quantify diagnostic mistakes. Their analysis determined that misdiagnosis frequencies ranged from 5 percent to 41 percent, with a pooled proportion in six core cohorts reaching 15 percent. Furthermore, the time required to uncover and rectify an incorrect assignment stretched from 0.3 to 15.9 years, showing how long errors can persist in clinical records. The authors also established that women were 2.1 times more likely to receive an erroneous diagnosis than men, while unrecognized underdiagnosis affected an estimated 36 percent of examined patients [7].
Specialists point out that academic referral centers tend to evaluate complex cases, which can raise recorded error rates. Dr. Thomas Flagiello, a neurologist at NYU Langone, explains that while misdiagnosis happens, the majority of cases evaluated in general practice are diagnosed correctly. Bruce Bebo adds that odds vary by patient population, so people should not assume their diagnosis is wrong without cause [1]. Even so, patients with unexpected symptom patterns benefit from a careful second look.
Biomarker Advances After Christina Applegate Misdiagnosis
To lower the risk of diagnostic errors, medical groups are refining imaging standards. In 2025, the International Advisory Committee on Clinical Trials in Multiple Sclerosis updated its diagnostic guidelines to integrate newer imaging clues. Clinicians can now inspect magnetic resonance imaging scans for specific structural markers, such as the central vein sign, where a small blood vessel runs directly through the center of a brain lesion. Specialists also look for paramagnetic rim lesions, which help distinguish multiple sclerosis from other brain changes [1].
The consequences of an inaccurate diagnosis carry real health risks for patients. Bebo points out that an incorrect label can expose someone to medications they do not need, while delaying treatments for the condition they actually have [1]. Because multiple sclerosis affects an estimated one to four people per thousand in the United States, getting an accurate assessment is important. Dr. De Jager encourages anyone dealing with confusing symptoms to seek a second opinion from an established specialist [5].
For Applegate, the immediate future involves searching for answers without a confirmed diagnosis [6]. She plans an investigation with specialists to find out what has caused her neuropathy and mobility issues since 2021 [2]. While navigating that uncertainty is difficult, her openness helps others understand the challenges of neurological diagnosis [5]. Her experience shows that finding the right diagnosis takes time, careful testing, and persistent advocacy.
- ONLINE NEWS Mogensen, J. F. (2026, October 20). Christina Applegate’s MS journey reveals the challenge of misdiagnosis. Scientific American. [Article Link]
- ONLINE NEWS Yu, Y.-J., & ABC News. (2026, October 20). Christina Applegate says she was misdiagnosed with MS. ABC News. [Article Link]
- ONLINE NEWS Breen, K. (2026, October 20). Christina Applegate reveals she was misdiagnosed with multiple sclerosis: “Not happy at all”. CBS News. [Article Link]
- ONLINE NEWS Stump, S. (2026, October 20). Christina Applegate tearfully shares she was misdiagnosed with MS: “Why did this happen?”. TODAY.com. [Article Link]
- ONLINE NEWS Silverman, H. (2026, October 20). MS symptoms explained after Christina Applegate reveals misdiagnosis. Newsweek. [Article Link]
- ONLINE NEWS Morrow, B. (2026, October 20). Christina Applegate reveals she was misdiagnosed with multiple sclerosis. USA TODAY. [Article Link]
- ACADEMIC JOURNAL Zürrer, W. E., Cannon, A. E., Ilchenko, D., Gaitán, M. I., Granberg, T., Piehl, F., Solomon, A. J., & Ineichen, B. V. (2024). Misdiagnosis and underdiagnosis of multiple sclerosis: A systematic review and meta-analysis. Multiple Sclerosis Journal, 30(11-12), 1409–1422. [Article Link]
APA 7: PerEXP Teamworks. (2026, October 21). Christina Applegate Misdiagnosis Exposes Diagnostic Limits in MS. PerEXP Teamworks. https://perexpteamworks.com/en/christina-applegate-misdiagnosis-ms-tests/
